Meeting of the National Advisory Council for Healthcare Research and Quality, 14730-14731 [2017-05588]

Download as PDF 14730 Federal Register / Vol. 82, No. 54 / Wednesday, March 22, 2017 / Notices asabaliauskas on DSK3SPTVN1PROD with NOTICES October 12, 2016. No comments were received. DATES: Submit comments on or before April 21, 2017. ADDRESSES: Submit comments regarding this burden estimate or any other aspect of this collection of information, including suggestions for reducing this burden to: Office of Information and Regulatory Affairs of OMB, Attention: Desk Officer for GSA, Room 10236, NEOB, Washington, DC 20503. Additionally submit a copy to GSA by any of the following methods: • Regulations.gov: http:// www.regulations.gov. Submit comments via the Federal eRulemaking portal by searching the OMB control number 9000–0138. Select the link ‘‘Comment Now’’ that corresponds with ‘‘Information Collection 9000–0138, Contract Financing’’. Follow the instructions provided on the screen. Please include your name, company name (if any), and ‘‘Information Collection 9000–0138, Contract Financing’’ on your attached document. • Mail: General Services Administration, Regulatory Secretariat Division (MVCB), 1800 F Street NW., Washington, DC 20405. ATTN: Ms. Sosa/IC 9000–0138. Instructions: Please submit comments only and cite Information Collection 9000–0138, in all correspondence related to this collection. Comments received generally will be posted without change to http:// www.regulations.gov, including any personal and/or business confidential information provided. To confirm receipt of your comment(s), please check www.regulations.gov, approximately two to three days after submission to verify posting (except allow 30 days for posting of comments submitted by mail). FOR FURTHER INFORMATION CONTACT: Ms. Camara Francis, Procurement Analyst, Acquisition Policy Division, at 202– 501–1448 or email camara.francis@ gsa.gov. SUPPLEMENTARY INFORMATION: A. Purpose The Federal Acquisition Streamlining Act (FASA) of 1994, Public Law 103– 355, provided authorities that streamlined the acquisition process and minimize burdensome Governmentunique requirements. Sections 2001 and 2051 of FASA substantially changed the statutory authorities for Government financing of contracts. Sections 2001(f) and 2051(e) provide specific authority for Government financing of purchases of commercial items; here, contract financing is permitted with certain VerDate Sep<11>2014 18:14 Mar 21, 2017 Jkt 241001 limitations. Likewise, sections 2001(b) and 2051(b) substantially revised the authority for Government financing of purchases of non-commercial items, by permitting contract financing on the basis of certain classes of measures of performance. To implement these changes, DOD, NASA, and GSA amended the FAR by revising Subparts 32.0, 32.1, and 32.5; by adding new Subparts 32.2 and 32.10; and by adding new clauses to 52.232. The coverage enables the Government to provide financing to assist in the performance of contracts for commercial items and provide financing for noncommercial items based on contractor performance. B. Annual Reporting Burden Public reporting burden for this collection of information is estimated to average 2 hours per request for commercial financing and 2 hours per request for performance-based financing, including time for reviewing instructions, searching existing data sources, gathering and maintaining the data needed, and completing and reviewing the collection of information. The annual reporting burden for commercial financing is estimated as follows: Respondents: 1,000. Responses per Respondent: 5. Total Responses: 5,000. Hours per Response: 2. Total Burden Hours: 10,000. The annual reporting burden for performance-based financing is estimated as follows: Respondents: 500. Responses per Respondent: 12. Total Responses: 6,000. Hours per Response: 2. Total Burden Hours: 12,000. C. Public Comments Public comments are particularly invited on: Whether this collection of information is necessary for the proper performance of functions of the FAR, and whether it will have practical utility; whether our estimate of the public burden of this collection of information is accurate, and based on valid assumptions and methodology; ways to enhance the quality, utility, and clarity of the information to be collected; and ways in which we can minimize the burden of the collection of information on those who are to respond, through the use of appropriate technological collection techniques or other forms of information technology. Obtaining Copies of Proposals: Requesters may obtain a copy of the information collection documents from the General Services Administration, PO 00000 Frm 00058 Fmt 4703 Sfmt 4703 Regulatory Secretariat Division (MVCB), 1800 F Street NW., Washington, DC 20405, telephone 202–501–4755. Please cite OMB Control No. 9000–0138, Contract Financing, in all correspondence. Dated: March 16, 2017. Lorin S. Curit, Director, Federal Acquisition Policy Division, Office of Governmentwide Acquisition Policy, Office of Acquisition Policy, Office of Governmentwide Policy. [FR Doc. 2017–05570 Filed 3–21–17; 8:45 am] BILLING CODE 6820–EP–P DEPARTMENT OF HEALTH AND HUMAN SERVICES Agency for Healthcare Research and Quality Meeting of the National Advisory Council for Healthcare Research and Quality Agency for Healthcare Research and Quality (AHRQ), HHS. ACTION: Notice of public meeting cancellation. AGENCY: In accordance with section 10(a) of the Federal Advisory Committee Act, 5 U.S.C. App. 2, this notice announces the cancellation of a meeting of the National Advisory Council for Healthcare Research and Quality. DATES: The meeting would have been held on Friday, March 24, 2017, from 8:30 a.m. to 2:45 p.m. ADDRESSES: The meeting would have been held at the Hubert H. Humphrey Building, Room 800, 200 Independence Avenue SW., Washington, DC 20201. FOR FURTHER INFORMATION CONTACT: Jaime Zimmerman, Designated Management Official, at the Agency for Healthcare Research and Quality, 5600 Fishers Lane, Mail Stop 06E37A, Rockville, Maryland, 20857, (301) 427– 1456. For press-related information, please contact Alison Hunt at (301) 427– 1244 or Alison.Hunt@ahrq.hhs.gov. SUPPLEMENTARY INFORMATION: SUMMARY: I. Purpose The National Advisory Council for Healthcare Research and Quality is authorized by Section 941 of the Public Health Service Act, 42 U.S.C. 299c. In accordance with its statutory mandate, the Council is to advise the Secretary of the Department of Health and Human Services and the Director of AHRQ on matters related to AHRQ’s conduct of its mission including providing guidance on (A) priorities for health care research, (B) the field of health care research E:\FR\FM\22MRN1.SGM 22MRN1 Federal Register / Vol. 82, No. 54 / Wednesday, March 22, 2017 / Notices including training needs and information dissemination on health care quality and (C) the role of the Agency in light of private sector activity and opportunities for public private partnerships. The Council is composed of members of the public, appointed by the Secretary, and Federal ex-officio members specified in the authorizing legislation. The Council did not have a quorum for the meeting scheduled for March 24th. Therefore, AHRQ is cancelling the meeting. The next meeting of the NAC is planned for July 26th. Sharon B. Arnold, Acting Director. [FR Doc. 2017–05588 Filed 3–21–17; 8:45 am] BILLING CODE 4160–90–P DEPARTMENT OF HEALTH AND HUMAN SERVICES [60-Day–17–17XR; Docket No. CDC–2017– 0027] Proposed Data Collection Submitted for Public Comment and Recommendations Centers for Disease Control and Prevention (CDC), Department of Health and Human Services (HHS). ACTION: Notice with comment period. AGENCY: The Centers for Disease Control and Prevention (CDC), as part of its continuing efforts to reduce public burden and maximize the utility of government information, invites the general public and other Federal agencies to take this opportunity to comment on proposed and/or continuing information collections, as required by the Paperwork Reduction Act of 1995. This notice invites comment on the donor registration form in support of the project titled ‘‘Acquisition of Freshly Drawn Whole Blood/Blood Products for Reference Diagnostic and Research Use.’’ DATES: Written comments must be received on or before May 22, 2017. ADDRESSES: You may submit comments, identified by Docket No. CDC–2017– 0027 by any of the following methods: • Federal eRulemaking Portal: Regulations.gov. Follow the instructions for submitting comments. • Mail: Leroy A. Richardson, Information Collection Review Office, Centers for Disease Control and Prevention, 1600 Clifton Road NE., MS– D74, Atlanta, Georgia 30329. Instructions: All submissions received must include the agency name and Docket Number. All relevant comments received will be posted without change asabaliauskas on DSK3SPTVN1PROD with NOTICES SUMMARY: VerDate Sep<11>2014 18:14 Mar 21, 2017 Jkt 241001 to Regulations.gov, including any personal information provided. For access to the docket to read background documents or comments received, go to Regulations.gov. Please note: All public comment should be submitted through the Federal eRulemaking portal (Regulations.gov) or by U.S. mail to the address listed above. FOR FURTHER INFORMATION CONTACT: To request more information on the proposed project or to obtain a copy of the information collection plan and instruments, contact the Information Collection Review Office, Centers for Disease Control and Prevention, 1600 Clifton Road NE., MS–D74, Atlanta, Georgia 30329; phone: 404–639–7570; Email: omb@cdc.gov. SUPPLEMENTARY INFORMATION: Under the Paperwork Reduction Act of 1995 (PRA) (44 U.S.C. 3501–3520), Federal agencies must obtain approval from the Office of Management and Budget (OMB) for each collection of information they conduct or sponsor. In addition, the PRA also requires Federal agencies to provide a 60-day notice in the Federal Register concerning each proposed collection of information, including each new proposed collection, each proposed extension of existing collection of information, and each reinstatement of previously approved information collection before submitting the collection to OMB for approval. To comply with this requirement, we are publishing this notice of a proposed data collection as described below. Comments are invited on: (a) Whether the proposed collection of information is necessary for the proper performance of the functions of the agency, including whether the information shall have practical utility; (b) the accuracy of the agency’s estimate of the burden of the proposed collection of information; (c) ways to enhance the quality, utility, and clarity of the information to be collected; (d) ways to minimize the burden of the collection of information on respondents, including through the use of automated collection techniques or other forms of information technology; and (e) estimates of capital or start-up costs and costs of operation, maintenance, and purchase of services to provide information. Burden means the total time, effort, or financial resources expended by persons to generate, maintain, retain, disclose or provide information to or for a Federal agency. This includes the time needed to review instructions; to develop, acquire, install and utilize technology and systems for the purpose of collecting, validating and verifying information, processing and PO 00000 Frm 00059 Fmt 4703 Sfmt 4703 14731 maintaining information, and disclosing and providing information; to train personnel and to be able to respond to a collection of information, to search data sources, to complete and review the collection of information; and to transmit or otherwise disclose the information. Proposed Project Acquisition of Freshly-Drawn Whole Blood/Blood Products for Reference Diagnostic and Research Use—Existing Information Collection in Use Without an OMB Control Number—National Center for Emerging and Zoonotic Infectious Diseases (NCEZID), Centers for Disease Control and Prevention (CDC). Background and Brief Description The CDC seeks a three-year OMB approval to collect information in support of fresh blood/blood products for laboratory programs. The CDC regularly requires freshly drawn whole blood, serum, plasma, mononuclear white cell and platelet concentrates for research purposes, for reagents, and as ‘‘normal’’ control materials. To enhance the safety of CDC personnel handling these materials, the blood/blood products, or the donors thereof, must be screened for evidence of possible infections by specific testing. At the same time, donor confidentiality must be assured and adequate counseling must be available, in case any specimens or donors test positive for certain transmissible infections. The donor registration form referenced by this request is a brief, 11question form that establishes the availability of volunteer donors to participate in the donor program to fill this need for fresh blood/blood products for CDC. The registration form captures donors’ availability to donate, interest in various types of donations, smoking history, exercise background, alcohol consumption, measles vaccination history, cholesterol test history, and medications background. Donors required to maintain the CDC donor pool are recruited by contract program managers often by referral of current donors, directed outreach for new donors by email, occasional posting of notices in areas frequented by CDC personnel, or at local universities for possible student populations. All donor information is collected and protected by medical professionals with donor/patient confidentiality protected. Information from this form is only used to determine donor eligibility for blood product requests to be used by CDC laboratory programs. Approximately 25 volunteer donors are enrolled annually. E:\FR\FM\22MRN1.SGM 22MRN1

Agencies

[Federal Register Volume 82, Number 54 (Wednesday, March 22, 2017)]
[Notices]
[Pages 14730-14731]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 2017-05588]


=======================================================================
-----------------------------------------------------------------------

DEPARTMENT OF HEALTH AND HUMAN SERVICES

Agency for Healthcare Research and Quality


Meeting of the National Advisory Council for Healthcare Research 
and Quality

AGENCY: Agency for Healthcare Research and Quality (AHRQ), HHS.

ACTION: Notice of public meeting cancellation.

-----------------------------------------------------------------------

SUMMARY: In accordance with section 10(a) of the Federal Advisory 
Committee Act, 5 U.S.C. App. 2, this notice announces the cancellation 
of a meeting of the National Advisory Council for Healthcare Research 
and Quality.

DATES: The meeting would have been held on Friday, March 24, 2017, from 
8:30 a.m. to 2:45 p.m.

ADDRESSES: The meeting would have been held at the Hubert H. Humphrey 
Building, Room 800, 200 Independence Avenue SW., Washington, DC 20201.

FOR FURTHER INFORMATION CONTACT: Jaime Zimmerman, Designated Management 
Official, at the Agency for Healthcare Research and Quality, 5600 
Fishers Lane, Mail Stop 06E37A, Rockville, Maryland, 20857, (301) 427-
1456. For press-related information, please contact Alison Hunt at 
(301) 427-1244 or Alison.Hunt@ahrq.hhs.gov.

SUPPLEMENTARY INFORMATION:

I. Purpose

    The National Advisory Council for Healthcare Research and Quality 
is authorized by Section 941 of the Public Health Service Act, 42 
U.S.C. 299c. In accordance with its statutory mandate, the Council is 
to advise the Secretary of the Department of Health and Human Services 
and the Director of AHRQ on matters related to AHRQ's conduct of its 
mission including providing guidance on (A) priorities for health care 
research, (B) the field of health care research

[[Page 14731]]

including training needs and information dissemination on health care 
quality and (C) the role of the Agency in light of private sector 
activity and opportunities for public private partnerships. The Council 
is composed of members of the public, appointed by the Secretary, and 
Federal ex-officio members specified in the authorizing legislation. 
The Council did not have a quorum for the meeting scheduled for March 
24th. Therefore, AHRQ is cancelling the meeting. The next meeting of 
the NAC is planned for July 26th.

Sharon B. Arnold,
Acting Director.
[FR Doc. 2017-05588 Filed 3-21-17; 8:45 am]
 BILLING CODE 4160-90-P